Eyenovia Inc.

News & Events

Press Releases

In The Media

1. Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program

   GlobeNewswire JUN 23, 2025 8:30 AM EDT
   The significant HYPE token position, acquired at an average price of approximately $34 per token,...
   READ ARTICLE

2. Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

   PR Newswire JUN 18, 2025 2:04 PM EDT
   Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings PR N...
   READ ARTICLE

3. Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

   GlobeNewswire JUN 18, 2025 8:32 AM EDT
   LAGUNA HILLS, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Ey...
   READ ARTICLE

4. Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

   GlobeNewswire JUN 17, 2025 2:55 PM EDT
   Announces private placement EYEN to become first U.S.-based publicly listed company to ho...
   READ ARTICLE

5. Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities

   GlobeNewswire JUN 4, 2025 8:45 AM EDT
   PALM BEACH, Fla., June 04, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - ...
   READ ARTICLE

6. Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

   GlobeNewswire MAY 19, 2025 5:30 PM EDT
   Eyenovia and Betaliq continue to negotiate a binding merger agreement consistent with the previou...
   READ ARTICLE

7. Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

   GlobeNewswire APR 10, 2025 7:00 AM EDT
   NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia ...
   READ ARTICLE

8. Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

   GlobeNewswire MAR 20, 2025 7:00 AM EDT
   Combination, if successful, would create a new publicly-listed eye care company combining Betaliq...
   READ ARTICLE

9. Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

   GlobeNewswire FEB 26, 2025 7:00 AM EST
   NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenoviaȁ...
   READ ARTICLE

10. Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

    GlobeNewswire FEB 24, 2025 7:00 AM EST
    NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenoviaȁ...
    READ ARTICLE